Board of Directors

Has served as a Director of the Company since April 2007. Since July 1, 2009, Dr. Emerson has served as Vice Chair for Clinical Programs and Chief of Clinical Pathology at the University of Southern California Keck School of Medicine, Los Angeles, California. From 1994 to 2009, Dr. Emerson was on the faculty of the University of California, Irvine School of Medicines where she served as Chief of Clinical Pathology and from 2000 to 2009, also served as the Vice Chair for Clinical Programs, Department of Pathology and Laboratory Medicine.

Mr. David Moatazedi has served as the President and Chief Executive Officer, and as a member of the of Board of Directors of Evolus, Inc. (NASDAQ: EOLS), since May 2018. Evolus is a publicly traded life sciences company headquartered in Orange County, California, with a market capitalization of approximate $500 million.  From March 2017 to June 2020, David also served as an independent board member of Obalon Therapeutics, a publicly traded life sciences company that was later merged into ReShape Lifesciences Inc.  From 2016 to 2018, David served as Senior Vice President at Allergan Inc. (“Allergan”), and division head of the U.S. Medical Aesthetics division. Prior to Evolus, Mr. Moatazedi worked in various other leadership positions within Allergan since 2005, including Vice President, Sales and Marketing of the U.S. Facial Aesthetics and the U.S. Plastic Surgery Divisions.  Before Allergan, Mr. Moatazedi was a district manager for Novartis Pharmaceuticals. Mr. Moatazedi holds, an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Mr. Eric B. Chin, CPA, had served as a Director of the Company since June 2025. He has served as the CFO of Akido Labs, a venture-backed, A.I. powered medical network since January 2023. He also has served as a Board Member and Treasurer for Rhode Island Primary Care Physicians Corporation since December 2023. Prior to joining Akido, Chin was the CFO of Astrana Health (formerly known as Apollo Medical Holdings) a member of the S&P SmallCap 600. Chin also previously held leadership roles at Public Storage within its real estate division, and Alexandria Real Estate Equities, both of which are publicly traded and members of the S&P 500. He began his career at Ernst & Young and is an active Certified Public Accountant (CPA) in California. Chin received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.